<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="1" ids="16474">NADPH</z:chebi> oxidase is a major complex that produces reactive oxygen species (ROSs) during the ischemic period and aggravates brain damage and cell <z:hpo ids='HP_0011420'>death</z:hpo> after ischemic injury </plain></SENT>
<SENT sid="1" pm="."><plain>Although many approaches have been tested for preventing production of ROSs by <z:chebi fb="1" ids="16474">NADPH</z:chebi> oxidase in ischemic brain injury, the regulatory mechanisms of <z:chebi fb="1" ids="16474">NADPH</z:chebi> oxidase activity after <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> are still unclear </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of this study is identifying <z:chebi fb="0" ids="2781">apocynin</z:chebi> as a critical modulator of <z:chebi fb="1" ids="16474">NADPH</z:chebi> oxidase and elucidating its role as a neuroprotectant in an experimental model of <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> in rat </plain></SENT>
<SENT sid="3" pm="."><plain>Treatment of <z:chebi fb="0" ids="2781">apocynin</z:chebi> 5min before of reperfusion attenuated <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> in rats </plain></SENT>
<SENT sid="4" pm="."><plain>Administration of <z:chebi fb="0" ids="2781">apocynin</z:chebi> showed marked reduction in <z:mpath ids='MPATH_124'>infarct</z:mpath> size compared with that of control rats </plain></SENT>
<SENT sid="5" pm="."><plain>Medial carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAo)-induced <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> was also associated with an increase in, nitrotyrosine formation, as well as IL-1β expression, IκB degradation and ICAM expression in ischemic regions </plain></SENT>
<SENT sid="6" pm="."><plain>These expressions were markedly inhibited by the treatment of <z:chebi fb="0" ids="2781">apocynin</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain>We also demonstrated that <z:chebi fb="0" ids="2781">apocynin</z:chebi> reduces levels of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> (TUNEL, Bax and Bcl-2 expression) resulting in a reduction in the <z:mpath ids='MPATH_124'>infarct</z:mpath> volume in <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-reperfusion brain injury </plain></SENT>
<SENT sid="8" pm="."><plain>This new understanding of <z:chebi fb="0" ids="2781">apocynin</z:chebi> induced adaptation to ischemic stress and <z:mp ids='MP_0001845'>inflammation</z:mp> could suggest novel avenues for clinical intervention during ischemic and <z:e sem="disease" ids="C1290884" disease_type="Disease or Syndrome" abbrv="">inflammatory diseases</z:e> </plain></SENT>
</text></document>